These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26817127)

  • 1. [NONALCOHOLIC FATTY LIVER DISEASE: DIAGNOSTIC, SYMPTOMS, TREATMENT. GUIDELINES WERE APPROVED BY THE XV GASTROENTEROLOGICAL SCIENTIFIC SOCIETY OF RUSSIA IN 2015].
    Lazebnik LB; Radchenko VG; Golovanova EV; Zvenigorodskaya LA; Konev YV; Seliverstov PV; Sitkin SI; Tkachenko EI; Aylamazayn EK; Vlasov NN; Kornienko EA; Novikova VP; Horoshinina LP; Zhestkova NV; Oreshko LS; Dudanova OP; Dobrica VP; Turyeva LV; Tirikova OV; Kozlova NM; Eliseev SM; Gumerov RR; Vencak EV
    Eksp Klin Gastroenterol; 2015; (7):85-96. PubMed ID: 26817127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.
    Iacob S; Ester C; Lita M; Ratziu V; Gheorghe L
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):183-9. PubMed ID: 27308649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease: diagnosis and investigation.
    Nascimbeni F; Loria P; Ratziu V
    Dig Dis; 2014; 32(5):586-96. PubMed ID: 25034292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Mikolašević I; Orlić L; Štimac D; Mavrinac V; Colić M; Ostojić D; Milić S
    Lijec Vjesn; 2016 May; 138(5-6):159-163. PubMed ID: 29182828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An interpretation of European guidelines for the diagnosis and treatment of nonalcoholic fatty liver disease].
    Xin FZ; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):403-5. PubMed ID: 27465941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature review.
    Schattenberg JM; Anstee QM; Caussy C; Bugianesi E; Popovic B
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1253-1266. PubMed ID: 34493137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From NAFLD in clinical practice to answers from guidelines.
    Nascimbeni F; Pais R; Bellentani S; Day CP; Ratziu V; Loria P; Lonardo A
    J Hepatol; 2013 Oct; 59(4):859-71. PubMed ID: 23751754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of fatty liver disease with the metabolic syndrome.
    Machado MV; Cortez-Pinto H
    Expert Rev Gastroenterol Hepatol; 2014 Jul; 8(5):487-500. PubMed ID: 24665862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
    Serfaty L
    Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
    Polanco-Briceno S; Glass D; Stuntz M; Caze A
    BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [NON-ALCOHOLIC FATTY LIVER DISEASE].
    Bukmir L; Smokrović H; Diminić-Lisica I; Ljubotina A; Popović B
    Acta Med Croatica; 2015 Nov; 69(4):305-10. PubMed ID: 29083841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.
    Aller R; Fernández-Rodríguez C; Lo Iacono O; Bañares R; Abad J; Carrión JA; García-Monzón C; Caballería J; Berenguer M; Rodríguez-Perálvarez M; Miranda JL; Vilar-Gómez E; Crespo J; García-Cortés M; Reig M; Navarro JM; Gallego R; Genescà J; Arias-Loste MT; Pareja MJ; Albillos A; Muntané J; Jorquera F; Solà E; Hernández-Guerra M; Rojo MÁ; Salmerón J; Caballería L; Diago M; Molina E; Bataller R; Romero-Gómez M
    Gastroenterol Hepatol; 2018 May; 41(5):328-349. PubMed ID: 29631866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
    Luo J; Xu L; Li J; Zhao S
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAFLD: a multisystem disease.
    Byrne CD; Targher G
    J Hepatol; 2015 Apr; 62(1 Suppl):S47-64. PubMed ID: 25920090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of Nonalcoholic Fatty Liver Disease.
    Lonardo A; Leoni S; Alswat KA; Fouad Y
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.